Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019.

ABSTRACT:

Importance

Melanoma accounts for most of the deaths due to skin cancer. In the past decade, effective US Food and Drug Administration (FDA)-approved therapies for melanoma have emerged.

Objective

To review changes in the long-term melanoma mortality rate (MMR) trends in the US and determine whether they have any temporal association with the FDA approval of new agents.

Design, setting, and participants

This cross-sectional study used population data from the Surveillance, Epidemiology, and End Results (SEER) database and retrospectively reviewed the age-adjusted MMR trends in adult patients (aged ≥18 years) from 1975 to 2019 in the US population. The timeline of the FDA approvals for melanoma treatment was also reviewed. Data were analyzed from March 15 to August 15,

SUBMITTER: Kahlon N 

PROVIDER: S-EPMC9856246 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature